Live Breaking News & Updates on Arch Venture Partners Xii
Stay updated with breaking news from Arch venture partners xii. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Neumora Therapeutics, Inc. (NASDAQ:NMRA – Get Free Report) major shareholder Arch Venture Partners Xii, Llc purchased 30,192 shares of the business’s stock in a transaction that occurred on Tuesday, November 7th. The stock was acquired at an average price of $11.50 per share, for a total transaction of $347,208.00. Following the acquisition, the insider now […] ....
Neumora Therapeutics (NASDAQ:NMRA – Free Report) had its price target reduced by JPMorgan Chase & Co. from $21.00 to $20.00 in a report released on Wednesday morning, Benzinga reports. They currently have an overweight rating on the stock. Other research analysts have also recently issued reports about the stock. William Blair assumed coverage on shares […] ....
Neumora Therapeutics, Inc. (NASDAQ:NMRA) Receives $22.83 Consensus Target Price from Analysts theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Bank of America initiated coverage on shares of Neumora Therapeutics (NASDAQ:NMRA – Free Report) in a research note released on Tuesday, Marketbeat Ratings reports. The brokerage issued a buy rating and a $18.00 price target on the stock. NMRA has been the topic of a number of other research reports. Royal Bank of Canada assumed […] ....
Shares of Neumora Therapeutics, Inc. (NASDAQ:NMRA – Get Free Report) have received a consensus rating of “N/A” from the zero research firms that are covering the stock, MarketBeat Ratings reports. NMRA has been the subject of a number of research reports. Royal Bank of Canada assumed coverage on Neumora Therapeutics in a research note on […] ....